Evidence map›Paper›PMID 42218140›Full record

ArticleNature communications2026

Brieflow: an integrated computational pipeline for high-throughput analysis of optical pooled screening data.

Matteo Di Bernardo, Roshan S Kern, Ana Karla Cepeda Diaz, Alexa Mallar, Samuel J Choi, Andrew Nutter-Upham, Sebastian Lourido, Paul C Blainey, Iain Cheeseman

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. The one-week automated genome-wide optical pooled screen.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Matteo Di BernardoWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Roshan S KernWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Ana Karla Cepeda DiazWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2033-461X
Alexa MallarWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Samuel J ChoiWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Andrew Nutter-UphamWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Sebastian LouridoWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5237-1095
Paul C BlaineyBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4889-8783
Iain CheesemanWhitehead Institute for Biomedical Research, Cambridge, MA, USA. icheese@wi.mit.edu.ORCID http://orcid.org/0000-0002-3829-5612

Funding

Molecular Analysis of Kinetochore FunctionR35GM126930 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Iain McPherson Cheeseman · 2018 to 2026
$7.0M
High-content optical pooled genome-wide screens of SARS-CoV-2 infectionR01HG009283 · NHGRI · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK · 2017 to 2020
$4.8M
Control of parasite invasion by a microneme protein complex conserved in ApicomplexansR01AI144369 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LOURIDO, SEBASTIAN · 2020 to 2024
$2.4M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) R01AI144369Massachusetts Institute of Technology (MIT) UROP ProgramMassachusetts Life Sciences Center (MLSC) Data Science Internship ProgramNational Science Foundation (NSF) 000955563NHGRI NIH HHS R01 HG009283NIAID NIH HHS R01 AI144369NIGMS NIH HHS R35 GM126930U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R01HG009283U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM126930
6 · The paper itself

Abstract

Optical pooled screening (OPS) has emerged as a powerful technique for functional genomics, enabling researchers to link genetic perturbations with complex cellular morphological phenotypes at scale. However, OPS data analysis presents challenges due to massive datasets, complex multi-modal integration requirements, and the absence of standardized frameworks. Here, we present Brieflow, a computational pipeline for end-to-end analysis of fixed-cell optical pooled screening data. We demonstrate Brieflow's capabilities through reanalysis of a CRISPR-Cas9 screen encompassing 5072 fitness-conferring genes, processing more than 70 million cells with multiple phenotypic markers. To accelerate biological interpretation, we additionally present MozzareLLM, a framework leveraging large language models to identify biological processes within phenotypic clusters and prioritize gene candidates for experimental validation. Our combined analysis recovers coherent biological modules missed by existing analytical approaches, including five core mitochondrial sub-programs absent from the original study. The modular design and open-source implementation of Brieflow facilitates the integration of new analytical components while ensuring computational reproducibility and improved performance for the use of high-content phenotypic screening in biological discovery.

Indexed as

Computational BiologyGenomicsHigh-Throughput Screening AssaysCRISPR-Cas SystemsHumansLarge Language ModelsPhenotypePooled TestingReproducibility of ResultsSoftware

Identifiers

PMID42218140
PMCPMC13392126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.